Therapeutic potential of resveratrol in Alzheimer's disease - Test2 - elhamkhani - TriplyDB

Therapeutic potential of resveratrol in Alzheimer's disease

Therapeutic potential of resveratrol in Alzheimer's disease

http://www.wikidata.org/entity/Q30855117

about

Dietary interventions to extend life span and health span based on calorie restriction Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function Antioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal Results Resveratrol: A Focus on Several Neurodegenerative Diseases Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease Resveratrol Directly Binds to Mitochondrial Complex I and Increases Oxidative Stress in Brain Mitochondria of Aged Mice Pretreatment with Resveratrol Prevents Neuronal Injury and Cognitive Deficits Induced by Perinatal Hypoxia-Ischemia in Rats Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease Resveratrol acts not through anti-aggregative pathways but mainly via its scavenging properties against Aβ and Aβ-metal complexes toxicity Resveratrol protects C6 astrocyte cell line against hydrogen peroxide-induced oxidative stress through heme oxygenase 1 The resveratrol trimer miyabenol C inhibits β-secretase activity and β-amyloid generation Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-β peptide degradation.AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism.Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia.Small-molecule activators of AMP-activated protein kinase (AMPK), RSVA314 and RSVA405, inhibit adipogenesis.Polyphenols and aging.Neuronutrition and Alzheimer's disease Neuroprotective and metabolic effects of resveratrol: therapeutic implications for Huntington's disease and other neurodegenerative disorders.Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatment.Targeting multiple pathogenic mechanisms with polyphenols for the treatment of Alzheimer's disease-experimental approach and therapeutic implications.Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment.Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade Resveratrol up-regulates AMPA receptor expression via AMP-activated protein kinase-mediated protein translation.Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease.Nutrition in severe dementia Hepatoprotective and Antioxidant Potential of Organic and Conventional Grape Juices in Rats Fed a High-Fat Diet.A Strategy to Employ Clitoria ternatea as a Prospective Brain Drug Confronting Monoamine Oxidase (MAO) Against Neurodegenerative Diseases and Depression Identification of potent small-molecule inhibitors of STAT3 with anti-inflammatory properties in RAW 264.7 macrophages.Chronic depression as a model disease for cerebral aging Alzheimer's Disease Risk and Progression: The Role of Nutritional Supplements and their Effect on Drug Therapy Outcome Duality of Antidepressants and Neuroprotectants.Protein folding and aggregation into amyloid: the interference by natural phenolic compounds Natural products as a source of Alzheimer's drug leads.Neuroinflammation, neurodegeneration, and depression.Effects of combined phytochemicals on skin tumorigenesis in SENCAR mice.Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases.

P2860

Q24595003-99767372-F3E4-4CA8-B2DC-051BC97ABEF1 Q24617577-4E610BE4-F3E3-425F-B851-FE22A69FBAD2 Q26774897-74BDB1AB-48CA-4601-860B-19961B0044D1 Q26800952-93332E85-7215-45D7-92C7-19EB7047C00A Q26830740-16EFABAB-CAC3-44AD-9A0F-3EB6811FA296 Q27021700-6ACCC00B-95AC-4E7B-B3D7-2E4605D65C3E Q27335789-2AEC75A9-9504-4A63-A8AE-9783D0F30394 Q27346253-FA09028D-40B5-4A19-B4F6-E27B4368EF6D Q28259585-EA001EBF-D99F-4870-8EEB-551B9D7D5D62 Q28478772-CBED43F4-9EFF-4EC4-BADF-41F5CB01F925 Q28488046-D2D56E4B-E803-407F-BF2A-65E35CBEDFB5 Q28543122-02FE5AC4-66E5-4A13-81D1-2B2C4694845E Q33695751-269EF53E-41EE-44D3-913B-E832059359FE Q33726605-0B0A6025-FB89-4142-A1E8-DC7E7FFE5A2E Q33859252-F284F1DE-B07F-46DE-B8D3-0FAAFA9D42D5 Q33925399-4682E7EC-CE05-499C-8CBA-72FCE4F2AA77 Q33957220-0FB9C184-788F-42DF-A0A9-3DA909806BBC Q34099466-0CF630D7-62CD-40CC-9A66-BF2952D01BF3 Q34215149-9FAA3E67-DE9F-40D6-9B45-F8A0B911DC0B Q34407220-A9CBADA2-87AE-4DF0-8DFF-35813B3D2CDF Q34412322-9030B2C7-B3A1-4A92-B4AE-B321A2DEE10E Q34443537-6BB9458A-4FD3-4DF0-A90A-0E770815AB8F Q35224775-6870A82D-4208-4E32-8CA8-3D8B2BF41598 Q35658827-2E19B4C5-DABC-4A76-A616-D054D09E5D60 Q35738555-EA91807B-FD55-4DA2-9D1C-4836A1900B80 Q35765716-75C46B60-C4C9-47A2-B2FC-7BAB225AF65F Q35974826-1232CC17-1BF8-4D2E-B809-93D09AF3322B Q36335037-F1A97281-D7DF-455E-8964-D9B15120F943 Q36378454-E4E5A218-02A2-4248-8D9D-CBE63DF39192 Q36575930-3010DAFA-1EDC-4393-9F9E-7D22B812397A Q36755176-80D46970-F54D-4FA9-BCD7-F318A78DBEFC Q36781717-8C58A758-8760-4D4D-9FC9-D4B5B30425F6 Q36944840-D0126FCE-E5EF-4E2B-A292-4C4FE59F89E2 Q37007345-839A4D37-C4C4-4C44-9B09-BFF733DB1F15 Q37029561-E9C82E6A-644C-4F86-AA0C-0EE20D4CB58E Q37116106-AF078EE7-A19B-442F-B0AD-9CA575BFD943 Q37209501-D077DCD0-7C16-4CC1-AAA2-F1FB02837C7F Q37559812-7CDB72B3-05AA-4997-A9BE-606F32D9B654 Q37675866-233841BA-3E43-4045-A902-DBB669899568 Q37689874-71F91FB3-24F9-4EED-B56A-BD2FD02F7BA6

P2860

Therapeutic potential of resveratrol in Alzheimer's disease

http://www.wikidata.org/entity/Q30855117

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Therapeutic potential of resveratrol in Alzheimer's disease

@ast

Therapeutic potential of resveratrol in Alzheimer's disease

@en

type

label

Therapeutic potential of resveratrol in Alzheimer's disease

@ast

Therapeutic potential of resveratrol in Alzheimer's disease

@en

prefLabel

Therapeutic potential of resveratrol in Alzheimer's disease

@ast

Therapeutic potential of resveratrol in Alzheimer's disease

@en

P1433

Q30855117-732B62E6-AE41-4A6E-86D4-5541C7D5A45A

P1476

Q30855117-C1C0F372-61F8-44F0-8A9A-F9C4C7AB63BB

P2093

Q30855117-1030C7CF-326D-4F53-AEE3-0E00DEDD41AB

Q30855117-23857910-4F7F-4041-A298-553993DD6054

Q30855117-240CAC43-76AE-4159-B949-C2F49920BB26

P275

Q30855117-613D1A27-08EA-4ED5-88F2-C9ECF92DCE13

P2860

Q30855117-0330FC92-7B1B-40FF-9CB1-3274674C0D38

Q30855117-06094AD5-9DA7-411C-9AA8-92C3302E187A

Q30855117-0FBB8308-D384-4022-9013-A39FCB45220A

Q30855117-10C40F01-FB0A-4356-99E3-2A300D3D8494

Q30855117-1B11ED6C-6D84-4E3A-8E5B-6DF1526BA2CE

Q30855117-1E7C81E0-F60F-4701-AC4D-667518F5F6F2

Q30855117-1F212085-0F41-4F27-BC93-CC7FEBB6BEA8

Q30855117-27B67EA3-76F1-41C6-A66D-E676C4EF2467

Q30855117-2BE4696A-D724-4793-998A-298A36F6D1F0

Q30855117-2BEDD2CF-EBB9-4B07-8CD0-A941A59798A9

P2888

Q30855117-40E28705-565F-4DA9-8830-0EFCB1762DA2

P304

Q30855117-2D467527-6073-42BD-BB02-1973F1F3239D

P31

Q30855117-DEAA9419-CA48-4D94-B513-947E519AB0C8

P356

Q30855117-4BC9DD50-148B-4E63-B7B5-3155EF2191F5

P478

Q30855117-83D7CEAD-7026-4472-AF7B-8A2F3BEA2EA1

P50

Q30855117-0EE42A8F-0C5E-4886-AE44-3C9C6D4C871E

Q30855117-5F82D5C9-70D6-442E-BBD7-315ED3E7029E

P5008

Q30855117-5CB408ED-159B-4D27-AF5F-7E0B2E6CEF1E

P577

Q30855117-62B73C86-BBE9-4779-ADD3-F05BFD4D1FD4

P6179

Q30855117-EB77B514-2AAA-4A3E-933F-7928D2A16C42

P698

Q30855117-9B7179E9-D244-4B08-A9C6-89305CE5BE4A

P921

Q30855117-6345244F-E355-4466-9F10-5FCA756A1B4B

Q30855117-9B2FD5D2-D410-4133-9E7C-9FE5DB6CA0B4

Q30855117-9B97967D-D51C-4A59-BB77-158A950A2412

P932

Q30855117-582EAB08-BE23-4F12-A2DA-B2B30F7503C0

P356

1471-2202-9-S2-S6

P1433

BMC Neuroscience

P1476

Therapeutic potential of resveratrol in Alzheimer's disease

@en

P2093

Haitian Zhao

http://www.w3.org/2001/XMLSchema#string

Peter Davies

http://www.w3.org/2001/XMLSchema#string

Ute Dreses-Werringloer

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions.

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Resveratrol improves health and survival of mice on a high-calorie diet

Alzheimer's disease: genes, proteins, and therapy

A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}

Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis

P2888

1471-2202-9-s2-s6

P304

S6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2202-9-S2-S6

http://www.w3.org/2001/XMLSchema#string

P478

9 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P50

Philippe Marambaud

Valérie Vingtdeux

P5008

P577

2008-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1003354581

http://www.w3.org/2001/XMLSchema#string

P698

19090994

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

mechanism of action

P932

2604890

http://www.w3.org/2001/XMLSchema#string